Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma Y Sonoda, T Ozawa, Y Hirose, KD Aldape, M McMahon, MS Berger, ... Cancer research 61 (13), 4956-4960, 2001 | 308 | 2001 |
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma Y Sonoda, T Ozawa, KD Aldape, DF Deen, MS Berger, RO Pieper Cancer research 61 (18), 6674-6678, 2001 | 262 | 2001 |
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients Y Sonoda, T Kumabe, T Nakamura, R Saito, M Kanamori, Y Yamashita, ... Cancer science 100 (10), 1996-1998, 2009 | 183 | 2009 |
Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase … T Kayama, S Sato, K Sakurada, J Mizusawa, R Nishikawa, Y Narita, ... Journal of Clinical Oncology 36 (33), 3282-3289, 2018 | 165 | 2018 |
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion T Kawaguchi, Y Sonoda, I Shibahara, R Saito, M Kanamori, T Kumabe, ... Journal of neuro-oncology 129, 505-514, 2016 | 151 | 2016 |
A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes Y Sato, H Sato, K Naka, S Furuya, H Tsukiji, K Kitagawa, Y Sonoda, ... Archives of virology 156, 1345-1358, 2011 | 137 | 2011 |
Functional Evaluation of p53 and PTEN Gene Mutations in Gliomas H Kato, S Kato, T Kumabe, Y Sonoda, T Yoshimoto, S Kato, SY Han, ... Clinical Cancer Research 6 (10), 3937-3943, 2000 | 125 | 2000 |
Metabolism of 32-hydroxy-24, 25-dihydrolanosterol by purified cytochrome P-45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 … Y Aoyama, Y Yoshida, Y Sonoda, Y Sato Journal of Biological Chemistry 262 (3), 1239-1243, 1987 | 113 | 1987 |
Clinical usefulness of 11C-MET PET and 201Tl SPECT for differentiation of recurrent glioma from radiation necrosis Y Sonoda, T Kumabe, T Takahashi, R Shirane, T Yoshimoto Neurologia medico-chirurgica 38 (6), 342-348, 1998 | 110 | 1998 |
Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Y Sonoda, T Yoshimoto, T Sekiya Oncogene 11 (10), 2145-2149, 1995 | 107 | 1995 |
Long-term survivors of glioblastoma: clinical features and molecular analysis Y Sonoda, T Kumabe, M Watanabe, Y Nakazato, T Inoue, M Kanamori, ... Acta neurochirurgica 151, 1349-1358, 2009 | 105 | 2009 |
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors K Fukuoka, Y Kanemura, T Shofuda, S Fukushima, S Yamashita, ... Acta neuropathologica communications 6, 1-18, 2018 | 92 | 2018 |
Deformylation of 32-oxo-24, 25-dihydrolanosterol by the purified cytochrome P-45014DM (lanosterol 14 α-demethylase) from yeast evidence confirming the intermediate step of … Y Aoyama, Y Yoshida, Y Sonoda, Y Sato Journal of Biological Chemistry 264 (31), 18502-18505, 1989 | 90 | 1989 |
Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis M Kanamori, T Kumabe, R Saito, Y Yamashita, Y Sonoda, H Ariga, ... Journal of Neurosurgery: Pediatrics 4 (6), 506-514, 2009 | 86 | 2009 |
Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models T Inoue, Y Yamashita, M Nishihara, S Sugiyama, Y Sonoda, T Kumabe, ... Neuro-oncology 11 (2), 151-157, 2009 | 85 | 2009 |
Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas Y Sonoda, I Shibahara, T Kawaguchi, R Saito, M Kanamori, M Watanabe, ... Brain tumor pathology 32, 99-104, 2015 | 84 | 2015 |
Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas H Kon, Y Sonoda, T Kumabe, T Yoshimoto, T Sekiya, Y Murakami Oncogene 16 (2), 257-263, 1998 | 77 | 1998 |
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma Y Narita, Y Arakawa, F Yamasaki, R Nishikawa, T Aoki, M Kanamori, ... Neuro-oncology 21 (3), 348-359, 2019 | 76 | 2019 |
Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients M Kanamori, T Higa, Y Sonoda, S Murakami, M Dodo, H Kitamura, ... Neuro-oncology 17 (4), 555-565, 2015 | 70 | 2015 |
O6-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free … Y Sonoda, M Yokosawa, R Saito, M Kanamori, Y Yamashita, T Kumabe, ... International journal of clinical oncology 15, 352-358, 2010 | 70 | 2010 |